December 3, 1982 First Successful Human Heart Implant of a Permanent Artificial Heart (Barney Clark)

On December 3, 1982, you'd witness one of medicine's most defining moments as Barney Clark became the first person to receive a permanent artificial heart. Clark was dying from end-stage congestive heart failure with no viable options left. Surgeon William DeVries led a team at the University of Utah Hospital, implanting the Jarvik-7 device, which worked immediately. Clark survived 112 days, and what happened during that time changed cardiac medicine forever.

Key Takeaways

• On December 2–3, 1982, surgeon William DeVries implanted the Jarvik-7 artificial heart into Barney Clark at the University of Utah Hospital.
• Clark received the implant because end-stage congestive heart failure left him dying with no viable conventional treatment options.
• The Jarvik-7 used pressurized air and polyurethane ventricles to mechanically replicate the pumping function of a biological heart.
• Clark survived 112 days post-implant but endured severe complications including seizures, infections, a broken valve, and extreme immobility.
• The case reshaped cardiac medicine by driving improvements in materials, power systems, surgical techniques, and experimental device regulations.

Why Barney Clark Needed a Permanent Artificial Heart

Barney Clark didn't just need a new heart—he needed a miracle. By 1982, Clark, a retired dentist from Seattle, had reached end stage congestive heart failure. His heart had deteriorated so severely that conventional treatments could no longer sustain him. He was essentially dying, with limited options available to extend his life in any meaningful way.

A traditional heart transplant wasn't a viable path forward given his condition and circumstances. Surgeons at the University of Utah determined that an experimental total artificial heart represented his only real chance at survival. Clark understood the risks—the surgery was unproven, and the device had never been permanently implanted in a human. Yet facing certain death, he chose to move forward, becoming a pivotal figure in medical history.

How the Jarvik-7 Artificial Heart Actually Worked

The Jarvik-7 didn't beat like a natural heart—it pumped using pressurized air. Its pneumatic mechanics relied on external air compressors pushing air into two artificial ventricles made from polyurethane and supported by aluminum and titanium components. When compressed air entered each chamber, it squeezed a flexible diaphragm, forcing blood out and through the body.

You'd notice the valve design used four mechanical valves that opened and closed with each pumping cycle, mimicking what your natural heart valves do. This controlled blood flow direction and prevented backflow.

The system connected to a compressor weighing roughly 400 pounds, which tethered Clark to a machine constantly. The device replaced his heart's pumping function entirely, keeping him alive through mechanical force rather than biological tissue. Similarly, Spirit's science instruments relied on a radiation-hardened RAD6000 processor to handle navigation and scientific data collection across more than 2,000 Martian days of operation.

Inside Barney Clark's December 1982 Artificial Heart Surgery

On December 2, 1982, surgeons at the University of Utah Hospital removed Barney Clark's failing heart and replaced it with the Jarvik-7, marking the first time a permanent artificial heart had been implanted in a human. William DeVries led the surgical team, coordinating surgical team dynamics across a carefully organized group of specialists who'd trained extensively for this procedure.

The operation required precise attachment of the device's components to the remaining cardiac tissue. Once connected, the Jarvik-7 began pumping immediately. You can imagine the tension in that operating room as doctors confirmed the artificial heart was functioning.

The surgery triggered immediate media ethics debates about how much detail reporters should disclose regarding an experimental patient's condition, privacy, and the risks he'd willingly accepted.

The Complications Clark Faced While Living on an Artificial Heart

Although the surgery itself went smoothly, Clark's post-implant life was defined by a relentless series of complications. He battled persistent infection risks tied to the external connections required to power the device. Device tethering to a 400-pound air compressor kept him largely immobile, stripping away any semblance of normal life.

Beyond limited movement, he endured seizures, air leaks, a broken valve, and recurring nosebleeds. Each complication demanded additional medical intervention, pushing his body further. He never left the hospital after the implant. While he survived 112 days—far longer than most expected—his experience exposed the harsh realities of early artificial heart technology. His case forced medical communities to confront serious questions about patient quality of life alongside technological achievement.

How the Jarvik-7 Implant Shaped the Future of Artificial Hearts

Despite its limitations, Clark's case with the Jarvik-7 set off a chain reaction in cardiac medicine that's still felt today. You can trace modern mechanical circulatory support devices directly back to lessons learned from those 112 days.

Researchers identified critical failures in biomedical materials, refining polymers and coatings to reduce clotting and infection risks. Regulators built stronger regulatory frameworks around experimental cardiac devices, creating clearer pathways for clinical trials and patient consent.

Engineers redesigned power systems, shrinking that 400-pound compressor into implantable components patients actually carry. Surgeons refined implantation techniques that now support thousands of patients awaiting transplants.

Clark didn't survive long, but his case transformed an experimental machine into the foundation of a legitimate medical discipline you'd recognize in today's advanced heart failure treatment. Similar to how knowledge exchange programs assist companies through short-term feasibility projects in emerging technologies, the lessons from Clark's implant were systematically shared across research institutions to accelerate the development of safer, more reliable cardiac devices.